Results 221 to 230 of about 69,436 (336)

From cockpit to community: Time to stop the use of first-generation H<sub>1</sub>-antihistamines. [PDF]

open access: yesWorld Allergy Organ J
Morais-Almeida M   +4 more
europepmc   +1 more source

Isolated Mast Cell–Mediated Angioedema: Clinically Different but Endotypically Similar to Chronic Spontaneous Urticaria

open access: yes
Clinical &Experimental Allergy, EarlyView.
Thomas Buttgereit   +10 more
wiley   +1 more source

Defensive medicine in dermatological practice – Dermatopathology as a mirror of structural challenges

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Defensive medicine refers to diagnostic or therapeutic actions taken primarily to reduce legal liability rather than to benefit the patient. In dermatopathology, defensive practices manifest in frequent immunohistochemical testing, overly cautious report phrasing, and reliance on multidisciplinary tumor boards.
Cornelia Sigrid Lissi Müller   +2 more
wiley   +1 more source

Concomitant Usage of H1‐Antihistamines and Immune Checkpoint Inhibitors on Cancer Patient Survival [PDF]

open access: gold
Y. H. Leung   +8 more
openalex   +1 more source

Exploring Perimenopausal and Menopausal Women's Oral Health Perceptions and Practices in Australia—A Qualitative Study

open access: yesGerodontology, EarlyView.
ABSTRACT Objective To explore the perceptions and practices of women in peri/menopause towards oral healthcare in Australia. Background Hormonal changes associated with peri/menopause create a period where women may be more prone to developing oral health problems, which can significantly impact their quality of life.
Namitha Thomas   +4 more
wiley   +1 more source

First successful protocol for desensitization to eptinezumab

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Background Eptinezumab is an anti‐calcitonin gene‐related peptide monoclonal antibody used for migraine prevention. During clinical trials, hypersensitivity to eptinezumab was described without a clear underlying mechanism. To determine if the reaction was immunoglobulin E–mediated, the team of Nice University Hospital (Nice, France) performed
Benoit Gerard   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy